ReP USP - Resultado da busca

Artigo de periodico
Hepatic and cardiac and iron overload detected by T2*magnetic resonance (MRI) in patients with myelodisplastic syndrome: a cross-sectional study (2019)
Mantovani, L. F; Santos, F. P. S; Perini, G. F; Nascimento, C. M. B; Silva, L. P; Wroclawski, C. K; Espósito, Breno Pannia ; Ribeiro, M. S. S; Velloso, Elvira Deolinda Rodrigues Pereira; Nomura, C. H; Kay, F. U; Baroni, R H; Hamerschlak, N; Schuster, S
Fonte: Leukemia Research. Unidades: IQ, FM
Assuntos: RESSONÂNCIA MAGNÉTICA, ANEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANTOVANI, L. F et al. Hepatic and cardiac and iron overload detected by T2*magnetic resonance (MRI) in patients with myelodisplastic syndrome: a cross-sectional study. Leukemia Research, v. 76, p. 53-57, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2018.12.001. Acesso em: 04 nov. 2024.
APA
Mantovani, L. F., Santos, F. P. S., Perini, G. F., Nascimento, C. M. B., Silva, L. P., Wroclawski, C. K., et al. (2019). Hepatic and cardiac and iron overload detected by T2*magnetic resonance (MRI) in patients with myelodisplastic syndrome: a cross-sectional study. Leukemia Research, 76, 53-57. doi:10.1016/j.leukres.2018.12.001
NLM
Mantovani LF, Santos FPS, Perini GF, Nascimento CMB, Silva LP, Wroclawski CK, Espósito BP, Ribeiro MSS, Velloso EDRP, Nomura CH, Kay FU, Baroni RH, Hamerschlak N, Schuster S. Hepatic and cardiac and iron overload detected by T2*magnetic resonance (MRI) in patients with myelodisplastic syndrome: a cross-sectional study [Internet]. Leukemia Research. 2019 ; 76 53-57.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2018.12.001
Vancouver
Mantovani LF, Santos FPS, Perini GF, Nascimento CMB, Silva LP, Wroclawski CK, Espósito BP, Ribeiro MSS, Velloso EDRP, Nomura CH, Kay FU, Baroni RH, Hamerschlak N, Schuster S. Hepatic and cardiac and iron overload detected by T2*magnetic resonance (MRI) in patients with myelodisplastic syndrome: a cross-sectional study [Internet]. Leukemia Research. 2019 ; 76 53-57.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2018.12.001
Artigo de periodico
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia (2018)
Brassesco, Maria Sol; Pezuk, Julia Alejandra; Cortez, Maria Angélica; Salomão, Karina Bezerra; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Leukemia Research. Unidades: FFCLRP, FMRP
Assuntos: LEUCEMIA, CRIANÇAS, PROGNÓSTICO, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria Sol et al. TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia. Leukemia Research, v. 74, p. 42-46, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2018.09.010. Acesso em: 04 nov. 2024.
APA
Brassesco, M. S., Pezuk, J. A., Cortez, M. A., Salomão, K. B., Scrideli, C. A., & Tone, L. G. (2018). TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia. Leukemia Research, 74, 42-46. doi:10.1016/j.leukres.2018.09.010
NLM
Brassesco MS, Pezuk JA, Cortez MA, Salomão KB, Scrideli CA, Tone LG. TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia [Internet]. Leukemia Research. 2018 ; 74 42-46.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2018.09.010
Vancouver
Brassesco MS, Pezuk JA, Cortez MA, Salomão KB, Scrideli CA, Tone LG. TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia [Internet]. Leukemia Research. 2018 ; 74 42-46.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2018.09.010
Artigo de periodico
Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience (2017)
Benicio, Mariana Tereza de Lira; Ribeiro, Ana Flávia Tibúrcio; Américo, Andre D.; Furtado, Felipe M.; Glória, Ana B.; Lima, Aleide S.; Santos, Silvana M.; Xavier, Sandra G.; Lucena-Araujo, Antonio R.; Fagundes, Evandro M.; Rego, Eduardo Magalhães
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: LEUCEMIA MIELOIDE AGUDA, SOBREVIVÊNCIA LIVRE DE DOENÇA, PROGNÓSTICO, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENICIO, Mariana Tereza de Lira et al. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience. Leukemia Research, v. 60, p. 109-114, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2017.07.005. Acesso em: 04 nov. 2024.
APA
Benicio, M. T. de L., Ribeiro, A. F. T., Américo, A. D., Furtado, F. M., Glória, A. B., Lima, A. S., et al. (2017). Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience. Leukemia Research, 60, 109-114. doi:10.1016/j.leukres.2017.07.005
NLM
Benicio MT de L, Ribeiro AFT, Américo AD, Furtado FM, Glória AB, Lima AS, Santos SM, Xavier SG, Lucena-Araujo AR, Fagundes EM, Rego EM. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience [Internet]. Leukemia Research. 2017 ; 60 109-114.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2017.07.005
Vancouver
Benicio MT de L, Ribeiro AFT, Américo AD, Furtado FM, Glória AB, Lima AS, Santos SM, Xavier SG, Lucena-Araujo AR, Fagundes EM, Rego EM. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience [Internet]. Leukemia Research. 2017 ; 60 109-114.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2017.07.005
Artigo de periodico
Reversine triggers mitotic catastrophe and apoptosis in K562 cells (2016)
Alves, Ana Paula Nunes Rodrigues; Machado Neto, João Agostinho ; Scheucher, Priscila Santos; Paiva, Helder Henrique; Simões, Belinda Pinto; Rego, Eduardo Magalhães; Traina, Fabiola
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: APOPTOSE, PROTEÍNAS QUINASES, LEUCEMIA MIELOIDE, DOENÇA CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Paula Nunes Rodrigues et al. Reversine triggers mitotic catastrophe and apoptosis in K562 cells. Leukemia Research, v. 48, p. 26-31, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2016.06.011. Acesso em: 04 nov. 2024.
APA
Alves, A. P. N. R., Machado Neto, J. A., Scheucher, P. S., Paiva, H. H., Simões, B. P., Rego, E. M., & Traina, F. (2016). Reversine triggers mitotic catastrophe and apoptosis in K562 cells. Leukemia Research, 48, 26-31. doi:10.1016/j.leukres.2016.06.011
NLM
Alves APNR, Machado Neto JA, Scheucher PS, Paiva HH, Simões BP, Rego EM, Traina F. Reversine triggers mitotic catastrophe and apoptosis in K562 cells [Internet]. Leukemia Research. 2016 ; 48 26-31.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2016.06.011
Vancouver
Alves APNR, Machado Neto JA, Scheucher PS, Paiva HH, Simões BP, Rego EM, Traina F. Reversine triggers mitotic catastrophe and apoptosis in K562 cells [Internet]. Leukemia Research. 2016 ; 48 26-31.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2016.06.011
Artigo de periodico
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 (2014)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Scopim-Ribeiro, Renata; Visconte, Valeria; Tabarroki, Ali; Duarte, Adriana S. S; Barra, Flávia F. C; Vassalo, José; Rogers, Heesun J; Lorand-Metze, Irene; Tiu, Ramon V; Costa, Fernando F; Saad, Sara T. Olalla; Traina, Fabiola
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: APOPTOSE (EFEITOS DE DROGAS), PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, v. 38, n. 10, p. 1245-1251, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2014.07.010. Acesso em: 04 nov. 2024.
APA
Campos, P. de M., Machado Neto, J. A., Scopim-Ribeiro, R., Visconte, V., Tabarroki, A., Duarte, A. S. S., et al. (2014). Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, 38( 10), 1245-1251. doi:10.1016/j.leukres.2014.07.010
NLM
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Vancouver
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Artigo de periodico
Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells (2014)
Machado Neto, João Agostinho ; Campos, Paula de Melo; Favaro, Patricia; Lazarini, Mariana; Lorand-Metze, Irene; Costa, Fernando Ferreira; Saad, Sara Teresinha Olalla; Traina, Fabiola
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: PROLIFERAÇÃO CELULAR, LEUCEMIA MIELOIDE AGUDA, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leukemia Research, v. 38, n. 2, p. 251-257, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.11.013. Acesso em: 04 nov. 2024.
APA
Machado Neto, J. A., Campos, P. de M., Favaro, P., Lazarini, M., Lorand-Metze, I., Costa, F. F., et al. (2014). Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leukemia Research, 38( 2), 251-257. doi:10.1016/j.leukres.2013.11.013
NLM
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Leukemia Research. 2014 ; 38( 2): 251-257.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.11.013
Vancouver
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Leukemia Research. 2014 ; 38( 2): 251-257.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.11.013
Artigo de periodico-carta/editorial
Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association? (2014)
Valera, Elvis Terci; Brassesco, María Sol; Tone, Luiz Gonzaga
Fonte: Leukemia Research. Unidades: FMRP, FFCLRP
Assuntos: LEUCEMIA (GENÉTICA), ELETROMAGNETISMO (EFEITOS;GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci e BRASSESCO, María Sol e TONE, Luiz Gonzaga. Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association?. Leukemia Research. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.leukres.2013.12.024. Acesso em: 04 nov. 2024. , 2014
APA
Valera, E. T., Brassesco, M. S., & Tone, L. G. (2014). Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association? Leukemia Research. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.leukres.2013.12.024
NLM
Valera ET, Brassesco MS, Tone LG. Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association? [Internet]. Leukemia Research. 2014 ; 38 289.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.12.024
Vancouver
Valera ET, Brassesco MS, Tone LG. Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association? [Internet]. Leukemia Research. 2014 ; 38 289.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.12.024
Artigo de periodico
MDR-1 and GST polymorphisms are involved in myelodysplasia progression (2013)
Palodetto, Bruna; Campos, Paula de Melo; Benites, Bruno Deltreggia; Chauffaille, Maria de Lourdes Lopes Ferrari; Velloso, Elvira Deolinda Rodrigues Pereira; Traina, Fabiola; Saad, Sara Teresinha Olalla
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: IDOSOS, DOENÇAS HEMATOLÓGICAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALODETTO, Bruna et al. MDR-1 and GST polymorphisms are involved in myelodysplasia progression. Leukemia Research, v. 37, n. 8, p. 970-973, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.04.024. Acesso em: 04 nov. 2024.
APA
Palodetto, B., Campos, P. de M., Benites, B. D., Chauffaille, M. de L. L. F., Velloso, E. D. R. P., Traina, F., & Saad, S. T. O. (2013). MDR-1 and GST polymorphisms are involved in myelodysplasia progression. Leukemia Research, 37( 8), 970-973. doi:10.1016/j.leukres.2013.04.024
NLM
Palodetto B, Campos P de M, Benites BD, Chauffaille M de LLF, Velloso EDRP, Traina F, Saad STO. MDR-1 and GST polymorphisms are involved in myelodysplasia progression [Internet]. Leukemia Research. 2013 ; 37( 8): 970-973.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.04.024
Vancouver
Palodetto B, Campos P de M, Benites BD, Chauffaille M de LLF, Velloso EDRP, Traina F, Saad STO. MDR-1 and GST polymorphisms are involved in myelodysplasia progression [Internet]. Leukemia Research. 2013 ; 37( 8): 970-973.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.04.024
Artigo de periodico
IL10 inversely correlates with the percentage of CD8+ cells in MDS patients (2013)
Lopes, Matheus Rodrigues; Traina, Fabiola; Campos, Paula de Melo; Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Machado, Helymar da Costa; Gilli, Simone Cristina Olenscki; Saad, Sara Teresinha Olalla; Favaro, Patricia
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: IDOSOS, DOENÇAS HEMATOLÓGICAS, REGULAÇÃO GÊNICA, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, v. 37, n. 5, p. 541-546, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.01.019. Acesso em: 04 nov. 2024.
APA
Lopes, M. R., Traina, F., Campos, P. de M., Pereira, J. K. N., Machado Neto, J. A., Machado, H. da C., et al. (2013). IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, 37( 5), 541-546. doi:10.1016/j.leukres.2013.01.019
NLM
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019
Vancouver
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019
Artigo de periodico-carta/editorial
Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta] (2012)
Brassesco, María Sol; Valera, Elvis Terci; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: PEDIATRIA, DOENÇAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María Sol et al. Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]. Leukemia Research. Kidlington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2012
APA
Brassesco, M. S., Valera, E. T., Scrideli, C. A., & Tone, L. G. (2012). Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]. Leukemia Research. Kidlington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Brassesco MS, Valera ET, Scrideli CA, Tone LG. Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]. Leukemia Research. 2012 ; 36( 1): e18-e19.[citado 2024 nov. 04 ]
Vancouver
Brassesco MS, Valera ET, Scrideli CA, Tone LG. Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]. Leukemia Research. 2012 ; 36( 1): e18-e19.[citado 2024 nov. 04 ]
Artigo de periodico
High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia (2011)
Araújo, Antonio Roberto Lucena de; Oliveira, Fábio Morato de; Cueva, Sabrina Dias Leite; Santos, Guilherme Augusto dos; Falcao, Roberto Passetto; Rego, Eduardo Magalhaes
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: LEUCEMIA MIELOIDE AGUDA (GENÉTICA), EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Antonio Roberto Lucena de et al. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leukemia Research, v. 35, n. 2, p. 260-264, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2010.07.034. Acesso em: 04 nov. 2024.
APA
Araújo, A. R. L. de, Oliveira, F. M. de, Cueva, S. D. L., Santos, G. A. dos, Falcao, R. P., & Rego, E. M. (2011). High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leukemia Research, 35( 2), 260-264. doi:10.1016/j.leukres.2010.07.034
NLM
Araújo ARL de, Oliveira FM de, Cueva SDL, Santos GA dos, Falcao RP, Rego EM. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia [Internet]. Leukemia Research. 2011 ; 35( 2): 260-264.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2010.07.034
Vancouver
Araújo ARL de, Oliveira FM de, Cueva SDL, Santos GA dos, Falcao RP, Rego EM. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia [Internet]. Leukemia Research. 2011 ; 35( 2): 260-264.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2010.07.034
Artigo de periodico
Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies (2011)
Dalmazzo, Leandro Felipe Figueiredo; Santana-Lemos, Bárbara Amélia Aparecida; Jácomo, Rafael Henriques; Garcia, Aglair Bergamo; Rego, Eduardo Magalhaes; Fonseca, Luiz Marcos da; Falcao, Roberto Passetto
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: LEUCEMIA MIELOIDE AGUDA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DALMAZZO, Leandro Felipe Figueiredo et al. Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies. Leukemia Research, v. 35, n. 5, p. 657-662, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2010.11.025. Acesso em: 04 nov. 2024.
APA
Dalmazzo, L. F. F., Santana-Lemos, B. A. A., Jácomo, R. H., Garcia, A. B., Rego, E. M., Fonseca, L. M. da, & Falcao, R. P. (2011). Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies. Leukemia Research, 35( 5), 657-662. doi:10.1016/j.leukres.2010.11.025
NLM
Dalmazzo LFF, Santana-Lemos BAA, Jácomo RH, Garcia AB, Rego EM, Fonseca LM da, Falcao RP. Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies [Internet]. Leukemia Research. 2011 ; 35( 5): 657-662.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2010.11.025
Vancouver
Dalmazzo LFF, Santana-Lemos BAA, Jácomo RH, Garcia AB, Rego EM, Fonseca LM da, Falcao RP. Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies [Internet]. Leukemia Research. 2011 ; 35( 5): 657-662.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2010.11.025
Artigo de periodico
mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor (2010)
Scrideli, Carlos Alberto; Cortez, Maria Angela Abdala; Yunes, Jose Andres; Queiroz, Rosane Gomes de Paula; Valera, Elvis Terci; Mata, Juliana França da; Toledo, Silvia Regina Caminada de; Ferreira, Priscila Pavoni; Lee, Maria Lúcia de Martino; Petrilli, Antônio Sérgio; Brandalise, Silvia Regina; Tone, Luiz Gonzaga
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: CRIANÇAS, EXPRESSÃO GÊNICA, LEUCEMIA, MEDULA ÓSSEA (AMOSTRA;DIAGNÓSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leukemia Research, v. 34, n. 1, p. 32-37, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2009.10.007. Acesso em: 04 nov. 2024.
APA
Scrideli, C. A., Cortez, M. A. A., Yunes, J. A., Queiroz, R. G. de P., Valera, E. T., Mata, J. F. da, et al. (2010). mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leukemia Research, 34( 1), 32-37. doi:10.1016/j.leukres.2009.10.007
NLM
Scrideli CA, Cortez MAA, Yunes JA, Queiroz RG de P, Valera ET, Mata JF da, Toledo SRC de, Ferreira PP, Lee ML de M, Petrilli AS, Brandalise SR, Tone LG. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor [Internet]. Leukemia Research. 2010 ; 34( 1): 32-37.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.007
Vancouver
Scrideli CA, Cortez MAA, Yunes JA, Queiroz RG de P, Valera ET, Mata JF da, Toledo SRC de, Ferreira PP, Lee ML de M, Petrilli AS, Brandalise SR, Tone LG. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor [Internet]. Leukemia Research. 2010 ; 34( 1): 32-37.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.007
Artigo de periodico
The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes (2010)
Costa, Simone V. da; Roela, Rosimeire A.; Junqueira, Mara Souza; Arantes, Camila; Brentani, Maria Mitzi
Fonte: Leukemia Research. Unidade: FM
Assuntos: PROTEÍNAS QUINASES, LEUCEMIA, NEOPLASIAS DA MEDULA ESPINHAL, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Simone V. da et al. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leukemia Research, v. 34, n. 4, p. 507-512, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2009.10.012. Acesso em: 04 nov. 2024.
APA
Costa, S. V. da, Roela, R. A., Junqueira, M. S., Arantes, C., & Brentani, M. M. (2010). The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leukemia Research, 34( 4), 507-512. doi:10.1016/j.leukres.2009.10.012
NLM
Costa SV da, Roela RA, Junqueira MS, Arantes C, Brentani MM. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes [Internet]. Leukemia Research. 2010 ; 34( 4): 507-512.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.012
Vancouver
Costa SV da, Roela RA, Junqueira MS, Arantes C, Brentani MM. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes [Internet]. Leukemia Research. 2010 ; 34( 4): 507-512.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.012
Artigo de periodico
New recurrent deletions in the PPAR"gama" and TP53 genes are associated with childhood myelodysplastic syndrome (2009)
Silveira, Cássia G. T.; Oliveira, Fábio Morato de; Valera, Elvis Terci; Ikoma, Maura R. V.; Borgonovo, Tamara; Cavalli, Iglenir João; Tone, Luiz Gonzaga; Rogatto, Silvia Regina
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: CRIANÇAS, ANORMALIDADES CROMOSSÔMICAS, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Cássia G. T. et al. New recurrent deletions in the PPAR"gama" and TP53 genes are associated with childhood myelodysplastic syndrome. Leukemia Research, v. 33, n. 1, p. 19-27, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2008.07.013. Acesso em: 04 nov. 2024.
APA
Silveira, C. G. T., Oliveira, F. M. de, Valera, E. T., Ikoma, M. R. V., Borgonovo, T., Cavalli, I. J., et al. (2009). New recurrent deletions in the PPAR"gama" and TP53 genes are associated with childhood myelodysplastic syndrome. Leukemia Research, 33( 1), 19-27. doi:10.1016/j.leukres.2008.07.013
NLM
Silveira CGT, Oliveira FM de, Valera ET, Ikoma MRV, Borgonovo T, Cavalli IJ, Tone LG, Rogatto SR. New recurrent deletions in the PPAR"gama" and TP53 genes are associated with childhood myelodysplastic syndrome [Internet]. Leukemia Research. 2009 ; 33( 1): 19-27.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.07.013
Vancouver
Silveira CGT, Oliveira FM de, Valera ET, Ikoma MRV, Borgonovo T, Cavalli IJ, Tone LG, Rogatto SR. New recurrent deletions in the PPAR"gama" and TP53 genes are associated with childhood myelodysplastic syndrome [Internet]. Leukemia Research. 2009 ; 33( 1): 19-27.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.07.013
Artigo de periodico
Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia (2009)
Silveira, Vanessa da Silva; Canalle, Renata; Scrideli, Carlos Alberto; Queiroz, Rosane Gomes de Paula; Bettiol, Heloisa; Valera, Elvis Terci; Tone, Luiz Gonzaga
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: POLIMORFISMO, XENOBIÓTICO, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Vanessa da Silva et al. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leukemia Research, v. 33, n. 7, p. 898-901, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2008.12.006. Acesso em: 04 nov. 2024.
APA
Silveira, V. da S., Canalle, R., Scrideli, C. A., Queiroz, R. G. de P., Bettiol, H., Valera, E. T., & Tone, L. G. (2009). Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leukemia Research, 33( 7), 898-901. doi:10.1016/j.leukres.2008.12.006
NLM
Silveira V da S, Canalle R, Scrideli CA, Queiroz RG de P, Bettiol H, Valera ET, Tone LG. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia [Internet]. Leukemia Research. 2009 ; 33( 7): 898-901.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.12.006
Vancouver
Silveira V da S, Canalle R, Scrideli CA, Queiroz RG de P, Bettiol H, Valera ET, Tone LG. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia [Internet]. Leukemia Research. 2009 ; 33( 7): 898-901.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.12.006
Artigo de periodico
Apoptosis induction by (+)'alfa'-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells (2009)
Freitas, Rosana Aparecida; Santos, Guilherme Augusto Silva dos; Teixeira, Hamilton Luiz Gimenes; Scheucher, Priscila Santos; Lucena-Araújo, Antonio Roberto; Lima, Ana Silvia Gouveia; Lima, Rodrigo Siqueira Abreu e; Garcia, Aglair Bergamo; Jordão Júnior, Alceu Afonso; Falcão, Roberto Passetto; Vannucchi, Hélio; Rego, Eduardo Magalhães
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: LEUCEMIA, ARSÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Rosana Aparecida et al. Apoptosis induction by (+)'alfa'-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Leukemia Research, v. 33, n. 7, p. 958-963, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2008.09.035. Acesso em: 04 nov. 2024.
APA
Freitas, R. A., Santos, G. A. S. dos, Teixeira, H. L. G., Scheucher, P. S., Lucena-Araújo, A. R., Lima, A. S. G., et al. (2009). Apoptosis induction by (+)'alfa'-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Leukemia Research, 33( 7), 958-963. doi:10.1016/j.leukres.2008.09.035
NLM
Freitas RA, Santos GAS dos, Teixeira HLG, Scheucher PS, Lucena-Araújo AR, Lima ASG, Lima RSA e, Garcia AB, Jordão Júnior AA, Falcão RP, Vannucchi H, Rego EM. Apoptosis induction by (+)'alfa'-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells [Internet]. Leukemia Research. 2009 ; 33( 7): 958-963.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.035
Vancouver
Freitas RA, Santos GAS dos, Teixeira HLG, Scheucher PS, Lucena-Araújo AR, Lima ASG, Lima RSA e, Garcia AB, Jordão Júnior AA, Falcão RP, Vannucchi H, Rego EM. Apoptosis induction by (+)'alfa'-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells [Internet]. Leukemia Research. 2009 ; 33( 7): 958-963.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.035
Trabalho de evento-resumo periodico
Clinical and cytogenetics findings in secondary myelodysplastic syndromes (MDS) - experience from a single institution in Brazil (2009)
Tanizawa, R.; Conchon, M.; Buccheri, V.; Beitler, B.; Dulley, F.; Velloso, E.
Fonte: Leukemia Research. Nome do evento: International Symposium on Myelodysplastic Syndromes (MDS). Unidade: FM
Assuntos: CITOGENÉTICA, ANEMIA (CLASSIFICAÇÃO), LEUCEMIA (CLASSIFICAÇÃO;TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANIZAWA, R. et al. Clinical and cytogenetics findings in secondary myelodysplastic syndromes (MDS) - experience from a single institution in Brazil. Leukemia Research. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2009
APA
Tanizawa, R., Conchon, M., Buccheri, V., Beitler, B., Dulley, F., & Velloso, E. (2009). Clinical and cytogenetics findings in secondary myelodysplastic syndromes (MDS) - experience from a single institution in Brazil. Leukemia Research. Oxford: Faculdade de Medicina, Universidade de São Paulo.
NLM
Tanizawa R, Conchon M, Buccheri V, Beitler B, Dulley F, Velloso E. Clinical and cytogenetics findings in secondary myelodysplastic syndromes (MDS) - experience from a single institution in Brazil. Leukemia Research. 2009 ; 33 S106-107.[citado 2024 nov. 04 ]
Vancouver
Tanizawa R, Conchon M, Buccheri V, Beitler B, Dulley F, Velloso E. Clinical and cytogenetics findings in secondary myelodysplastic syndromes (MDS) - experience from a single institution in Brazil. Leukemia Research. 2009 ; 33 S106-107.[citado 2024 nov. 04 ]
Artigo de periodico-carta/editorial
TCRG gene rearrangement patterns in brazilian children with all: an update. [Carta] (2009)
Ganazza, Mônica; Assumpção, Juliana Godoy; Araújo, Marcela de; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Brandalise, Silvia Regina; Yunes, José Andrés
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: LEUCEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GANAZZA, Mônica et al. TCRG gene rearrangement patterns in brazilian children with all: an update. [Carta]. Leukemia Research. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2009
APA
Ganazza, M., Assumpção, J. G., Araújo, M. de, Scrideli, C. A., Tone, L. G., Brandalise, S. R., & Yunes, J. A. (2009). TCRG gene rearrangement patterns in brazilian children with all: an update. [Carta]. Leukemia Research. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ganazza M, Assumpção JG, Araújo M de, Scrideli CA, Tone LG, Brandalise SR, Yunes JA. TCRG gene rearrangement patterns in brazilian children with all: an update. [Carta]. Leukemia Research. 2009 ;[citado 2024 nov. 04 ]
Vancouver
Ganazza M, Assumpção JG, Araújo M de, Scrideli CA, Tone LG, Brandalise SR, Yunes JA. TCRG gene rearrangement patterns in brazilian children with all: an update. [Carta]. Leukemia Research. 2009 ;[citado 2024 nov. 04 ]
Artigo de periodico
Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients (2009)
Oliveira, Adriana Morgan; Maria, Durvanei Augusto; Metzger, Martin Andreas ; Linardi, Camila; Giorgi, Ricardo Rodrigues; Moura, Fernanda; Martinez, Gracia Aparecida; Bydlowski, Sergio Paulo; Novak, Estela Maria
Fonte: Leukemia Research. Unidades: ICB, HU, FM
Assuntos: MIELOMA MÚLTIPLO (TERAPIA), ADJUVANTES IMUNOLÓGICOS, RECEPTORES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Adriana Morgan et al. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients. Leukemia Research, v. 33, n. 7, p. 970-973, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2008.09.018. Acesso em: 04 nov. 2024.
APA
Oliveira, A. M., Maria, D. A., Metzger, M. A., Linardi, C., Giorgi, R. R., Moura, F., et al. (2009). Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients. Leukemia Research, 33( 7), 970-973. doi:10.1016/j.leukres.2008.09.018
NLM
Oliveira AM, Maria DA, Metzger MA, Linardi C, Giorgi RR, Moura F, Martinez GA, Bydlowski SP, Novak EM. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients [Internet]. Leukemia Research. 2009 ; 33( 7): 970-973.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.018
Vancouver
Oliveira AM, Maria DA, Metzger MA, Linardi C, Giorgi RR, Moura F, Martinez GA, Bydlowski SP, Novak EM. Thalidomide treatment down-regulates SDF-1a and CXCR4 expression in multiple myeloma patients [Internet]. Leukemia Research. 2009 ; 33( 7): 970-973.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2008.09.018

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada